Login / Signup

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.

Kathryn SchnippelRebecca H BerhanuAndrew BlackCynthia FirnhaberNorah MaitisaDenise EvansEdina Sinanovic
Published in: BMC infectious diseases (2016)
Severe AE are common during the first 6 months of RR TB treatment and HIV-positive patients newly initiating ART have the highest subdistribution hazard ratio for severe AE, accounting for the competing risks of death and loss from treatment.
Keyphrases